loadpatents
name:-0.027952909469604
name:-0.015386819839478
name:-0.0026450157165527
Zhang; Fengqi Patent Filings

Zhang; Fengqi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zhang; Fengqi.The latest application filed is for "tricyclic compounds as sting agonists, and preparation methods and medicinal uses thereof".

Company Profile
2.17.22
  • Zhang; Fengqi - Tongliao CN
  • Zhang; Fengqi - Edison NJ
  • ZHANG; FENGQI - Tangliao CN
  • Zhang; Fengqi - Inner Mongolia CN
  • Zhang; Fengqi - New York NY
  • Zhang; Fengqi - Xi'an CN
  • Zhang; Fengqi - Xi'an City Shaanxi
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Water cooling radiator with a detachable water pump and a built-in fan
Grant 11,347,284 - Zhang May 31, 2
2022-05-31
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
Grant 11,339,156 - Acton, III , et al. May 24, 2
2022-05-24
Tricyclic Compounds As Sting Agonists, And Preparation Methods And Medicinal Uses Thereof
App 20220056044 - Liu; Dong ;   et al.
2022-02-24
Water-cooled Radiator Internally Provided With Semiconductor Refrigeration System And Fan
App 20220015263 - ZHANG; FENGQI
2022-01-13
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20210395224 - Acton, III; John J. ;   et al.
2021-12-23
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20210380580 - ACTON, III; John J. ;   et al.
2021-12-09
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
Grant 11,149,036 - Acton, III , et al. October 19, 2
2021-10-19
Water-cooling radiator
Grant 11,150,034 - Zhang October 19, 2
2021-10-19
Benzimidazole Derivatives as Modulators of Retinoid-Related Orphan Receptor Gamma (RORy) and Pharmaceutical Uses Thereof
App 20210171471 - Yan; Yinfa ;   et al.
2021-06-10
Novel Water Cooling Radiator With A Detachable Water Pump And A Built-in Fan
App 20200401198 - ZHANG; FENGQI
2020-12-24
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20200207758 - ACTON, III; John J. ;   et al.
2020-07-02
Novel Water-cooling Radiator
App 20200056848 - ZHANG; Fengqi
2020-02-20
6,7-dihydro-5H-pyrrolo[3,4-B]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptor
Grant 10,329,289 - Bao , et al.
2019-06-25
6,7-dihydro-5h-pyrrolo[3,4-b]pyridin-5-one Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20190062331 - BAO; JIANMING ;   et al.
2019-02-28
Phase rotator apparatus
Grant 10,075,174 - Bucossi , et al. September 11, 2
2018-09-11
Method for preparing structured graphene on SiC substrate based on Cl.sub.2 reaction
Grant 9,951,418 - Guo , et al. April 24, 2
2018-04-24
Preparation and use of 7a-amide substituted- 6,6-difluoro bicyclic himbacine derivatives as PAR-1 receptor antagonists
Grant 9,701,669 - Yang , et al. July 11, 2
2017-07-11
6,7-dihydro-5h-pyrrolo[3,4-b]pyridin-5-one Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor
App 20170183342 - BAO; JIANMING ;   et al.
2017-06-29
Preparation And Use Of 7a-amide Substituted- 6,6-difluoro Bicyclic Himbacine Derivatives As Par-1 Receptor Antagonists
App 20160185764 - Yang; Zhiqiang ;   et al.
2016-06-30
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
Grant 9,359,339 - Lin , et al. June 7, 2
2016-06-07
Cyclic amine substituted heterocyclic CETP inhibitors
Grant 9,353,101 - Acton, III , et al. May 31, 2
2016-05-31
Substituted benzopiperazines as CETP inhibitors
Grant 9,126,976 - Anand , et al. September 8, 2
2015-09-08
Method for Preparing Structured Graphene on SiC Substrate Based on CL2 Reaction
App 20150132506 - Guo; Hui ;   et al.
2015-05-14
Cyclic Amine Substituted Heterocyclic Cetp Inhibitors
App 20150111866 - Acton, III; John J. ;   et al.
2015-04-23
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use
App 20150018399 - LIN; SONGNIAN ;   et al.
2015-01-15
Benzopiperazine Derivatives As Cetp Inhibitors
App 20140357632 - Anand; Rajan ;   et al.
2014-12-04
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
Grant 8,436,015 - Lin , et al. May 7, 2
2013-05-07
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use
App 20110281795 - Lin; Songnian ;   et al.
2011-11-17
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use
App 20110172256 - Lin; Songnian ;   et al.
2011-07-14
Ophthalmic Compositions for Treating Ocular Hypertension
App 20090281154 - Doherty; James B. ;   et al.
2009-11-12
Ophthalmic Compositions for Treating Ocular Hypertension
App 20090062280 - Doherty; James B. ;   et al.
2009-03-05
Spirocyclic ureas, compositions containing such compounds and methods of use
App 20060116366 - Parmee; Emma R. ;   et al.
2006-06-01
Ophthalmic compositions for treating ocular hypertension
App 20050256117 - Chen, Meng Hsin ;   et al.
2005-11-17
Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides and uses thereof
Grant 6,642,237 - Tata , et al. November 4, 2
2003-11-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed